Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trial. // Appetite. – URL: https://www.sciencedirect.com/science/article/pii/S0003496726002141?dgcid=rss_sd_all
Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trial. Appetite. https://www.sciencedirect.com/science/article/pii/S0003496726002141?dgcid=rss_sd_all
“Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trial.” Appetite.
@article{article3642,
title = {Efficacy and safety of nerandomilast in patients with autoimmune disease-related progressive pulmonary fibrosis in the FIBRONEER-ILD trial},
journal = {Appetite},
url = {https://www.sciencedirect.com/science/article/pii/S0003496726002141?dgcid=rss_sd_all}
}
Publication date: January 2027 Source: Journal of Medical Imaging and Radiation Sciences, Volume 58, Issue 1 Author(s): Moulay Ali Nassiri, Narjes Moghadam, Ariane-Sophie Painchaud-Bouchard, Intissar Hadouch, Madan M. Rehani
Publication date: January 2027 Source: Journal of Medical Imaging and Radiation Sciences, Volume 58, Issue 1 Author(s): Marilack Viana D´Assunção Marques Loureiro, Renata Christian Martins Felix